Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis  C.A. Rushton, D.K. Satchithananda, P.W. Jones, U.T. Kadam  International Journal of Cardiology  Volume 196, Pages 98-106 (October 2015) DOI: 10.1016/j.ijcard.2015.05.180 Copyright © 2015 Terms and Conditions

Fig. 1 The risk of bias domain summary results. International Journal of Cardiology 2015 196, 98-106DOI: (10.1016/j.ijcard.2015.05.180) Copyright © 2015 Terms and Conditions

Fig. 2 Association between HF and diabetes comorbidity and all-cause mortality. Diabetes comorbidity defined by clinical diagnosis, administration code, prescription or patient self-report. Adjusted variables: age (A), gender (G), ethnicity (E), social (S), risk factors (R), comorbidities (C), aetiology (At), heart failure severity (Sv), drugs (D), laboratory (L), physical (P), ejection fraction (Ef). International Journal of Cardiology 2015 196, 98-106DOI: (10.1016/j.ijcard.2015.05.180) Copyright © 2015 Terms and Conditions

Fig. 3 Association between HF and COPD comorbidity and all-cause mortality. COPD comorbidity defined by clinical diagnosis, administration code or patient self-report. Adjusted variables: age (A), gender (G), ethnicity (E), social (S), risk factors (R), comorbidities (C), aetiology (At), heart failure severity (Sv), drugs (D), laboratory (L), physical (P), ejection fraction (Ef). International Journal of Cardiology 2015 196, 98-106DOI: (10.1016/j.ijcard.2015.05.180) Copyright © 2015 Terms and Conditions

Fig. 4 Association between HF and renal dysfunction comorbidity and all-cause mortality. Renal dysfunction comorbidity defined by eGFR <60mL/min/m2. Adjusted variables: age (A), gender (G), ethnicity (E), social (S), risk factors (R), comorbidities (C), aetiology (At), heart failure severity (Sv), drugs (D), laboratory (L), physical (P), ejection fraction (Ef). International Journal of Cardiology 2015 196, 98-106DOI: (10.1016/j.ijcard.2015.05.180) Copyright © 2015 Terms and Conditions

Fig. 5 Association between HF and renal dysfunction comorbidity and all-cause mortality stratified by severity. Adjusted variables: age (A), gender (G), ethnicity (E), social (S), risk factors (R), comorbidities (C), aetiology (At), heart failure severity (Sv), drugs (D), laboratory (L), physical (P), ejection fraction (Ef) *from prior systematic review [28]. **Test of association between the severity subgroups and the study effect estimates was performed using random effects meta-regression with Monte Carlo permutations to calculate the p value. International Journal of Cardiology 2015 196, 98-106DOI: (10.1016/j.ijcard.2015.05.180) Copyright © 2015 Terms and Conditions

Fig. 6 All-cause mortality risk by upper eGFR severity category limit in HF. All-cause mortality risk plotted against upper eGFR severity category limit (study defined) in HF. International Journal of Cardiology 2015 196, 98-106DOI: (10.1016/j.ijcard.2015.05.180) Copyright © 2015 Terms and Conditions

Fig. 7 Association between HF and renal dysfunction comorbidity and all-cause mortality stratified by severity change. Adjusted variables: age (A), gender (G), ethnicity (E), social (S), risk factors (R), comorbidities (C), aetiology (At), heart failure severity (Sv), drugs (D), laboratory (L), physical (P), ejection fraction (Ef) *from previous systematic review [29]. **Test of association between the severity subgroups and the study effect estimates was performed using random effects meta-regression with Monte Carlo permutations to calculate the p value. International Journal of Cardiology 2015 196, 98-106DOI: (10.1016/j.ijcard.2015.05.180) Copyright © 2015 Terms and Conditions